Cargando…

HOXB9 Overexpression Confers Chemoresistance to Ovarian Cancer Cells by Inducing ERCC-1, MRP-2, and XIAP

The purpose of this study was to identify the role of HOXB9 and associated molecular mechanism in acquiring chemoresistance to ovarian cancer cells. After establishing HOXB9-overexpressing cells (HOXB9-OE/SKOV3), cisplatin resistance-induced cells (Cis-R/SKOV3), and an ovarian cancer xenograft mouse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suh, Dong Hoon, Park, Wook Ha, Kim, Miseon, Kim, Kidong, No, Jae Hong, Kim, Yong Beom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865712/ https://www.ncbi.nlm.nih.gov/pubmed/36674764 http://dx.doi.org/10.3390/ijms24021249

Ejemplares similares

Elevated XIAP expression alone does not confer chemoresistance
por: Seeger, J M, et al.
Publicado: (2010)

Role of limonin in anticancer effects of Evodia rutaecarpa on ovarian cancer cells
por: Bae, Jae Ryul, et al.
Publicado: (2020)

Mutually exclusive antiproliferative effect of cell line‐specific HOX inhibition in epithelial ovarian cancer cell lines: SKOV‐3 vs RMUG‐S
por: Kim, Miseon, et al.
Publicado: (2020)

Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2021)

β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK
por: LI, QUENTIN Q., et al.
Publicado: (2013)

Use of a ring retractor to facilitate specimen removal in laparoscopic surgery
por: Hong, Deok Ho, et al.
Publicado: (2020)

Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer: A prospective observational study
por: Kim, Miseon, et al.
Publicado: (2019)

Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection
por: Yoo, Baraem, et al.
Publicado: (2017)

Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine
por: Adema, Auke D, et al.
Publicado: (2014)

Crocin suppresses multidrug resistance in MRP overexpressing ovarian cancer cell line
por: Mahdizadeh, Shadi, et al.
Publicado: (2016)

Feasibility of extended cycles of neoadjuvant chemotherapy in patients with advanced ovarian cancer in terms of prognosis and surgical outcomes
por: Kim, Nam Kyeong, et al.
Publicado: (2023)

MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance
por: Park, Young Tae, et al.
Publicado: (2013)

Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4
por: Lee, Hee-Jeong, et al.
Publicado: (2022)

MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2
por: Zhao, Henan, et al.
Publicado: (2016)

Clinical features that affect the number of pelvic lymph nodes harvested in patients with cervical cancer stage IB1 to IIA2
por: Choi, Yae Ji, et al.
Publicado: (2021)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors
por: Cremona, Mattia, et al.
Publicado: (2022)

Major clinical research advances in gynecologic cancer in 2016: 10-year special edition
por: Suh, Dong Hoon, et al.
Publicado: (2017)

CA19-9 elevation in ovarian mature cystic teratoma: Discrimination from ovarian cancer – CA19-9 level in teratoma
por: Cho, Hye-yon, et al.
Publicado: (2013)

USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B‐cell lymphoma
por: Engel, Katharina, et al.
Publicado: (2016)

Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma
por: Huang, Xiaoyue, et al.
Publicado: (2022)

Impact of Underweight after Treatment on Prognosis of Advanced-Stage Ovarian Cancer
por: Kim, Se Ik, et al.
Publicado: (2014)

Analysis of survivin, XIAP and FoxM1 as potential chemoresistance factors in breast cancer cells
por: Moraes, Gabriela N, et al.
Publicado: (2013)

Cervical Cancer in Women with Normal Papanicolaou Tests: A Korean Nationwide Cohort Study
por: Kim, Miseon, et al.
Publicado: (2021)

Tumor evolution and chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer
por: Zhang, Yiping, et al.
Publicado: (2018)

HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
por: Jung, C, et al.
Publicado: (2005)

Impact of HOXB7 overexpression on human adipose-derived mesenchymal progenitors
por: Foppiani, Elisabetta Manuela, et al.
Publicado: (2019)

Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer
por: Liu, Bowen, et al.
Publicado: (2018)

Clinicopathological Impact of ABCC1/MRP1 and ABCC4/MRP4 in Epithelial Ovarian Carcinoma
por: Bagnoli, Marina, et al.
Publicado: (2013)

FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells
por: Torres, Ángelo, et al.
Publicado: (2018)

Overexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer
por: Sui, Hongying, et al.
Publicado: (2016)

ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells
por: Huang, Yi-Jung, et al.
Publicado: (2022)

PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells
por: Kim, Boyun, et al.
Publicado: (2017)

Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study
por: Kim, Hee Seung, et al.
Publicado: (2016)

Establishment and Characterization of a Novel Multidrug Resistant Human Ovarian Cancer Cell Line With Heterogenous MRP7 Overexpression
por: Wang, Jing-Quan, et al.
Publicado: (2021)

MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms
por: Dumas, Pierre-Yves, et al.
Publicado: (2018)

HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2021)

RBM47 restrains renal cell carcinoma progression and chemoresistance through interacting with lncRNA HOXB-AS1
por: Su, Qingfu, et al.
Publicado: (2023)

Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells
por: SUN, YUE-LI, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p892uc3ioebl91lmm8d3q8gngl